Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401
Arti Hurria, Constance Cirrincione, Hyman Bernard Muss et al. · Journal of Clinical Oncology · 2011
PURPOSE: Factors captured in a geriatric assessment can predict morbidity and mortality in older adults, but are not routinely measured in cancer clinical trials. This study evaluated the implementation of a geriatric assessment tool in the cooperative group setting. PATIENTS AND METHODS: Patients age ≥ 65 with cancer, who enrolled on cooperative group cancer trials, were eligible to enroll on Cancer and Leukemia Group B (CALGB) 360401. They completed a geriatric assessment tool before initiation of protocol therapy, consisting of valid and reliable geriatric assessment measures which are primarily self-administered and require minimal resources and time by healthcare providers. The assessment measures functional status, comorbidity, cognitive function, psychological state, social support, and nutritional status. The protocol specified criteria for incorporation of the tool in future cooperative group trials was based on the time to completion and percent of patients who could complete their portion without assistance. Patient satisfaction with the tool was captured. RESULTS: Of the 93 patients who enrolled in this study, five (5%) met criteria for cognitive impairment and three did not complete the cognitive screen, leaving 85 assessable patients (median age, 72 years). The median time to complete the geriatric assessment tool was 22 minutes, 87% of patients (n = 74) completed their portion without assistance, 92% (n = 78) were satisfied with the questionnaire length, 95% (n = 81) reported no difficult questions, and 96% (n = 82) reported no upsetting questions. One hundred percent of health care professionals completed their portion. CONCLUSION: This brief, primarily self-administered geriatric assessment tool met the protocol specified criteria for inclusion in future cooperative group clinical trials.
Cited by 348 works. doi:10.1200/jco.2010.30.6985 Open-access PDF
Authors
- Arti Hurria
- Constance Cirrincione
- Hyman Bernard Muss
- Alice B. Kornblith
- William Thomas Barry
- Andrew S. Artz
- Linda E. Schmieder
- Rafat Ansari
- William P. Tew
- Douglas Jay Weckstein
- Jeffrey Kirshner
- Kayo Togawa
- Kurt Hansen
- Vani Katheria
- Richard Maury Stone
- Ilene A Galinsky
- John Postiglione
- Harvey Jay Cohen
References
- The Hospital Anxiety and Depression Scale
- The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
- The clinical evaluation of chemotherapeutic agents in cancer
- Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
- The MOS social support survey
- Evaluation of Chemotherapeutic Agents.
- SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
- Validation of a short Orientation-Memory-Concentration Test of cognitive impairment
- Prognostic effect of weight loss prior tochemotherapy in cancer patients
- Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials